BIRC5 and urinary bladder carcinoma: The rationale for investigating survivin as a prognostic marker in bladder cancer is based on its ability to inhibit apoptosis, promote proliferation and enhance angiogenesis, as well as its predominantly tumor-specific expression in adult tissues.